• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    E

    En+集团

    En+ Group
    企业
    446论文总数
    5,372引用总数

    En+ Group is an Anglo-Russian energy and metals company. It has a controlling stake in Rusal (the second largest producer of aluminium in the world) and is the world's largest independent hydropower generator in the world. It is listed on the London Stock Exchange.

    论文量&引用量时间轴

    机构学者

    论文(446)

    年份
    起
    –
    止
    排序
    1Advances in Targeting the AGEs-RAGE Pathway for the Treatment of Diabetic Kidney Disease
    Xiudan Li, Jingsong Mei

    Diabetic kidney disease (DKD) represents the most severe microvascular complication of diabetes and is the leading cause of end-stage renal disease globally. Its pathogenesis is complex, and current treatments have limitations. Advanced glycation end products (AGEs) and AGEs receptor (RAGE), constitute a core mechanism driving DKD progression. AGEs accumulate abnormally in high-glucose environments. Upon activation, RAGE mediates oxidative stress, chronic inflammation, renal fibrosis, dysregulation of autophagy, and apoptosis through multiple signaling pathways, ultimately leading to damage to the glomerular filtration barrier and exacerbating renal injury from multiple dimensions. This paper aims to elucidate the role of the AGEs-RAGE pathway in DKD and systematically review therapeutic strategies targeting this pathway. These include AGEs antagonists, AGEs-RAGE axis modulators, RAGE ligand binding inhibitors, antibody-based therapeutics, and traditional Chinese medicine. Additionally, clinical studies of AGEs-RAGE axis-targeted drug therapies for DKD are analyzed. This paper provides theoretical foundations for developing novel therapeutic drugs in DKD.

    2026Drug design, development and therapy(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2A Multidisciplinary Expert Consensus on Vitamin D Deficiency Diagnosis and Management in Saudi Arabia: Insights from a Modified Delphi Process
    Hisham A. Arab, Ashraf A. Amir, Metib Alotaibi, Fawzi Fahad Aljassir, Yasser A. Elmotaleb Gazar, Ali A. Alshehri, Sultan Al Dalbhi,Saud Alsifri, Ghazi S. Alotaibi, Abdulaziz Altwaim, Noha Mitwally, Mohammed Alomair

    Background: Vitamin D is essential for skeletal health and has been increasingly recognized for potential extra-skeletal benefits. Despite this, vitamin D deficiency remains prevalent, with corrective efforts focused on skeletal outcomes, whereas extra-skeletal benefits remain controversial due to conflicting evidence between small-scale studies and randomized control trials (RCTs). Furthermore, region-specific challenges are a barrier to first-line corrective strategies. Aim: This is the first Saudi-specific Delphi consensus, aiming to address skeletal and extra-skeletal outcomes, drive actionable corrective strategies, and encourage large-scale research in the Kingdom of Saudi Arabia (KSA). Methods: Eleven multidisciplinary key opinion leaders from KSA participated in a modified Delphi process involving a premeeting survey, two in-person meetings, and three iterative survey rounds. Consensus, predefined as >= 75% agreement consistent with established Delphi thresholds, was achieved across all 38 statements, covering the landscape of vitamin D deficiency, strategies for correction, maintenance, monitoring, and safety considerations. Results: Key consensus-based recommendations included: (i) vitamin D deficiency contributes to disease development, while correction could help improve outcomes; (ii) oral supplementation is the primary corrective strategy in the Saudi context; (iii) screening should be limited to patients in whom deficiency impacts disease or treatment, with empiric supplementation preferred otherwise; (iv) dosing regimens of 50,000 IU weekly for deficient or empirically treated patients and 1,000-2,000 IU daily or 50,000 IU monthly for sufficient patients and the general population; (v) conditions associated with reduced response to standard dosing are eligible for higher dose; (vi) indefinite maintenance with monitoring every 3-6 months for screened patients; (vii) expert-informed target serum 25-hydroxyvitamin D (25(OH)D) concentrations of >= 30 ng/mt for the general population, >= 50-<60 ng/mt for the elderly, and >= 70 ng/mt for patients with comorbidities. The recommendations for broad empiric supplementation, indefinite maintenance, and the >= 70 ng/mt target diverge from current international guidance and rest on expert consensus and limited evidence; they require prospective regional validation and should be applied with appropriate caution and safety monitoring. Conclusion: This framework provides the first Saudi-specific, Delphi-based recommendations for managing vitamin D deficiency, both skeletal and extra-skeletal and context for future research efforts.

    2026NUTRITION AND DIETARY SUPPLEMENTS(2026)
    引用
    AI阅读
    加入学术空间
    3Clinical Characteristics of Patients with Diabetes and Pulmonary Tuberculosis with Additional Extrapulmonary Involvement: A Retrospective Comparative Analysis
    Yang P, Huang C, Nie Y, Su S, Chen X

    Pengyan Yang,1,2 Caimao Huang,1 Yongcong Nie,2 Shilai Su,3 Xiaoyan Chen11Department of Endocrinology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China; 2Department of Endocrinology, National Clinical Research Center for Infectious Diseases, Shenzhen Third People’s Hospital, Shenzhen, Guangdong, 518112, People’s Republic of China; 3Department of Cardiac Electrophysiology, Shenzhen Second People’s Hospital, Shenzhen, 518035, People’s Republic of ChinaCorrespondence: Xiaoyan Chen, Email gzscxy@126.comBackground: Diabetes mellitus (DM) increases the risk of tuberculosis (TB), but clinical characteristics associated with extrapulmonary tuberculosis (EPTB) among patients with DM and pulmonary tuberculosis (PTB) remain insufficiently characterized. This study investigated the clinical features and factors associated with concomitant EPTB in patients with DM and PTB.Methods: This retrospective comparative study included 146 patients with DM and confirmed PTB who were admitted to Shenzhen Third People’s Hospital between April 2017 and October 2022. Patients were classified into a DM-EPTB group (PTB with concomitant EPTB; n = 56) and a DM-PTB group (PTB without EPTB; n = 90). Demographic characteristics, clinical features, laboratory and immunological indices, microbiological and pathological findings, chest computed tomography findings, glycemic management, and drug-resistance profiles were compared between groups. Multivariable logistic regression was used to identify factors associated with concomitant EPTB.Results: Among patients in the DM-EPTB group, 91.1% had extrapulmonary organ or site manifestations. The most frequently involved sites were the pericardium (23.4%), meninges (17.2%), and cervical lymph nodes (15.6%). Compared with patients in the DM-PTB group, those in the DM-EPTB group had lower body mass index, HbA1c, fasting plasma glucose, LDL-C, lymphocyte count, monocyte count, hemoglobin level, T-lymphocyte count, and helper T-lymphocyte count, but a higher monocyte-to-lymphocyte ratio (all P < 0.05). They also had longer hospital stays and more frequent readmissions. In multivariable logistic regression analysis, multiple hospitalizations (odds ratio [OR] = 2.300, 95% confidence interval [CI]: 1.134– 4.664; P = 0.021) and multiple pulmonary cavities (OR = 4.405, 95% CI: 1.349– 14.382; P = 0.014) were independently associated with concomitant EPTB.Conclusion: In patients with DM and PTB, concomitant EPTB was associated with poorer nutritional and immunological status, longer hospitalization, and greater disease complexity. Multiple hospitalizations and multiple pulmonary cavities were independently associated with concomitant EPTB. These findings support increased clinical vigilance and targeted assessment for EPTB in high-risk patients with DM and PTB.Keywords: diabetes mellitus, extrapulmonary tuberculosis, clinical characteristics, influencing factors

    2026Diabetes, Metabolic Syndrome and Obesity(2026)
    引用
    AI阅读
    加入学术空间
    4Construction of a Risk Prediction Model and Associative Path Analysis for Impaired Awareness of Hypoglycemia in People with Diabetes
    Wen X, Chen L, Mo Y, Guo H, Pei R, Lyu Y, Luo H, Wang J

    Xuexian Wen,&ast; Liyan Chen,&ast; Yali Mo, Hongzhen Guo, Rui Pei, Yuan Lyu, Huiqiong Luo, Jun Wang Department of Endocrinology, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Jun Wang, Department of Endocrinology, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen, 518020, People’s Republic of China, Email wangjun4622@163.comPurpose: We aimed to develop a risk prediction model for impaired awareness of hypoglycemia (IAH) in diabetes and explore the associations with clinical variables, providing a basis for targeted screening and personalized intervention.Patients and Methods: This cross-sectional study included 280 hospitalized people with diabetes (73.2% type 2 and 42.9% female) who experienced hypoglycemia between October 2023 and February 2024. We defined IAH as a Gold Scale score ≥ 4. We used binary logistic regression to construct the prediction model and structural equation modeling to analyze the associated pathways. Sensitivity analysis stratified by diabetes type verified the robustness of the results.Results: IAH affected 60.4% of the participants. Multivariate analysis revealed lower total cholesterol (TC) levels (aOR=0.819; 95% CI: 0.684– 0.981; P=0.030) as independent correlates. The model, which incorporated BMI, TC level, serum albumin level, peripheral neuropathy (PN) incidence, glomerular filtration rate (GFR), age, sex, and insulin use, showed moderate discriminative ability (AUC=0.630, P< 0.001), with high sensitivity (87.0%) and good calibration (Hosmer–Lemeshow test: P=0.743). Path analysis revealed that age indirectly influenced IAH risk (β=0.243) by decreasing the GFR (β=− 0.419; P< 0.001) and increasing PN risk (β=0.352; P< 0.001) and that a lower GFR (β=− 0.133; P=0.024) and TC level (β=− 0.131; P=0.024) were directly correlated with IAH risk. The serum albumin level was maintained by preserving the GFR (β=0.203; P< 0.001) and reducing PN risk (β=− 0.139; P=0.012).Conclusion: Higher BMI and lower TC are key correlates of IAH in hospitalized patients with diabetes. Age, GFR, serum albumin, and PN interact through direct and indirect pathways to affect the risk of IAH. This model, based on routine clinical indicators and with high sensitivity, represents a practical screening tool. Clinicians should perform early risk assessment and intervention in diabetic patients with higher BMI, lower TC, advanced age, malnutrition, renal insufficiency, or PN.Keywords: diabetes mellitus, hypoglycemia, impaired awareness of hypoglycemia, risk prediction model, path analysis

    2026Diabetes, Metabolic Syndrome and Obesity(2026)
    引用
    AI阅读
    加入学术空间
    5Exploring the Roles of Wnt Signaling Pathway and Non-Coding RNAs in COPD
    Xu Y, Lu P, Duan H, Liu F

    Yanling Xu,1 Peng Lu,1 Hanmei Duan,2 Feng Liu11Department of Emergency Medicine, Hengyang Central Hospital, Hengyang, Hunan, 421200, People’s Republic of China; 2Department of Endocrinology, Hengyang Central Hospital, Hengyang, Hunan, 421200, People’s Republic of ChinaCorrespondence: Feng Liu, Department of Emergency Medicine, Hengyang Central Hospital, 10 Yancheng Road, Yanfeng, Hengyang, Hunan, 421200, People’s Republic of China, Email 489642921@qq.comAbstract: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with one of the leading causes of global morbidity and mortality. Its core pathological features include irreversible airflow limitation, chronic airway inflammation, and lung tissue remodeling. In recent years, the key roles of the Wnt signaling pathway and non-coding RNAs (ncRNAs) in the pathogenesis of COPD have gained increasing attention. As a pivotal signaling cascade governing cell proliferation, differentiation and tissue repair, the Wnt pathway undergoes aberrant activation or suppression in COPD, linking closely to airway inflammation, alveolar epithelial damage and pulmonary fibrosis. Non-coding RNAs including miRNAs, lncRNAs and circRNAs modulate COPD pathogenesis via targeting core molecules of the Wnt pathway. This review summarizes the basic components and functions of the Wnt pathway and the classification and biological roles of ncRNAs and discusses their interactive mechanisms and therapeutic strategies in COPD. In addition, this review discusses the current controversies and future directions. Studies indicate that the synergistic regulatory network between the Wnt pathway and ncRNAs provides new molecular targets for the early diagnosis, prognosis assessment, and targeted therapy of COPD, highlighting potential avenues for future therapeutic development.Keywords: COPD, Wnt signaling pathway, ncRNAs

    2026International Journal of COPD(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 446 篇论文

    合作机构(100)

    贝勒大学合作论文 16
    亨利·福特医院合作论文 9
    明尼阿波利斯心脏研究所基金会合作论文 9
    哥伦比亚大学合作论文 8
    Massachusetts General Hospital,Harvard Medical School合作论文 7
    加利福尼亚大学圣地亚哥分校合作论文 7
    阿肯色医科大学合作论文 6
    埃默里大学合作论文 6
    贝斯以色列女执事医疗中心合作论文 6
    塞格德大学合作论文 5

    机构统计